1 Cannabis Stock I’m Buying While It’s Still Cheap

It’s not a popular choice, but it’s hard not to consider Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) right now.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’ll think I’m crazy, but with markets at lows not seen in years, perhaps the craziness of the market place is getting to me. I’ve been looking hard for cheap stocks to buy up while I can. Whereas before I would have to have a couple thousand dollars stashed away, right now I might need only a couple hundred bucks to really make an impact in the future of my portfolio.

Before I tell you about my cheap stock option, let me be honest. I’m not doing this with retirement around the corner, or even with my children’s education looming. I’m still in my thirties with the time and patience to wait out this and other storms headed my stock’s way. And there are likely to be a few more before it starts riding high again.

But if you’re like me and have the time, patience — and even a little cash to spend, I would put it toward cannabis producer Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB).

Here’s why.

Large — and in charge

Now I know what you’re thinking. Aurora has had major flack over the last year as the company continues to dilute shareholder prices by using that cash to make acquisitions – -and it hasn’t ended there. The company believed it would achieve profitability this year, but has since admitted that likely won’t happen, causing a major share selloff.

Today, the company has very little cash on hand, so investors are hoping the company finally make some sort of partnership to help bring in more funds.

This all sounds quite dire, and I’m not going to lie, things are not going well for Aurora right now. But it’s not alone. Aurora and all other cannabis companies are seeing a huge turning point happen in the industry. It should be expected that many cannabis producers could go bankrupt, and while Aurora has a lot of debt, I don’t think that will happen.

A large part of that is its size. Aurora is the second-largest producer of cannabis in the world, with 625,000 kilograms produced annually and a foothold in 25 countries, including Canada, where it can legally sell marijuana both recreationally and medicinally.

Low costs

Now it’s one thing to be able to produce a lot of pot, but it’s quite another to do it cheap. While the company is still working on paying off its debt of $1.4 billion by cutting costs even further, it’s already well placed among cannabis companies for being able to bring costs down.

While the cannabis producer in Canada produces cannabis at an average of $7.37 per gram, Aurora is light years ahead by doing what it promised and bringing it to below $1. In fact, as of writing that cost is at $0.85 per gram it had reduced the cost of producing cannabis to $0.85 per gram.

The company isn’t stopping there, and frankly it shouldn’t. If it’s not going to be making any partnerships any time soon, costs will have to be cut even further.

The company has announced it will be making some aggressive changes and restructuring to pay down its debt and get investors back on board.

Did I mention cheap?

The main point in all this is that I don’t believe Aurora is going any where, which leaves its share price of $1.21 as of writing at an absurdly cheap price. But don’t get me wrong: I don’t think it’s going to shoot back up to the levels seen back in 2018.

Those days are over for cannabis companies, at least for the next few years while legislation and sales iron out. But the company could easily double its stock price with even a hint of good news.

Granted, I think it will need more than a good earnings report — such as a partnership — but it will happen eventually. And when it does, you’ll be glad you were patient enough to weather the storm.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »